Table III.

Transfer of secondary MOG-specific Th2 and Th9 cells into C57BL/6 recipients

Clinical Disease
IncidenceMortalityMean Day of OnsetaMean Max. Scorea
2°Th22/60/621 ± 111.8 ± 1.3
2°Th98/80/812 ± 3.42.3 ± 1.3
2°Th173/30/319.3 ± 4.23.3 ± 0.3
  • a Averages calculated only from mice that developed clinical signs of EAE.